Suggestions
Chrystal Paulos
Associate Professor, Director of Translational Research, Cutaneous Malignancies @ Emory University
Chrystal Paulos, PhD, is a prominent cancer researcher and immunologist at Emory University. She serves as the Director of Translational Research in Cutaneous Malignancies at Winship Cancer Institute of Emory University.13 Here are some key details about Dr. Paulos:
Professional Background
Dr. Paulos is an Associate Professor in the Department of Surgery and the Department of Microbiology and Immunology at Emory University School of Medicine.3 She holds the David H. Lawson Professorship in Cancer Research, recognizing her accomplishments in the field.2
Research Focus
Her laboratory focuses on developing novel T cell-based therapies for cancer patients, particularly in melanoma.3 Dr. Paulos investigates mechanisms underlying protective immunity in solid tumors, with an emphasis on adoptive T cell transfer (ACT) therapy.1 Her work combines both basic and translational science to better understand and adapt human T cells for therapy.
Career Achievements
- Dr. Paulos has published over 100 high-impact articles, accumulating more than 11,000 citations.2
- Her research is funded by various institutional, national, federal, and industry grants.2
- She is a member of professional organizations such as the American Association of Immunologists and the Society for Immunotherapy of Cancer.3
Education and Training
- PhD in Chemistry from Purdue University (2004)
- Postdoctoral fellowships at the NIH and University of Pennsylvania2
Leadership and Mentorship
Dr. Paulos is known for her commitment to mentoring and advancing her trainees. She has helped many of her team members secure funding from organizations like the NIH and American Cancer Society.2 Additionally, she advocates for women in science and works to create a diverse and inclusive research environment.2
Dr. Paulos was inspired to pursue cancer research as a child when her grandmother was diagnosed with breast cancer.1 This personal experience drives her dedication to improving cancer treatments and giving hope to patients and their families.
